Connexins are the primary components of gap junctions, providing direct links between cells under many physiological processes. Here, we demonstrate that in addition to this canonical role, Connexins act as transcriptional regulators. We show that Connexin 43 (Cx43) controls neural crest cell migration in vivo by directly regulating N-cadherin transcription. This activity requires interaction between Cx43 carboxy tail and the basic transcription factor-3, which drives the translocation of Cx43 tail to the nucleus. Once in the nucleus they form a complex with PolII which directly binds to the N-cadherin promoter. We found that this mechanism is conserved between amphibian and mammalian cells. Given the strong evolutionary conservation of connexins across vertebrates, this may reflect a common mechanism of gene regulation by a protein whose function was previously ascribed only to gap junctional communication.
G ap junctions are transmembrane complexes of connexin proteins that allow intercellular communication and the transfer of ions and small signaling molecules between adjacent cells 1 . In addition to their channel functions at the plasma membrane, connexins can produce small fragments or isoforms that are present in different cellular compartments including the nucleus 2 and thus may function in alternative processes, such as gene expression 3, 4 .
The mutual regulation in the assembly of gap and adherens junctions 5, 6 suggests a possible coordination in the expression of their constituent proteins. Collective cell migration, which is fundamental for morphogenesis and cancer invasion 7 , depends on both gap and adherens junctions 8 . In mice, the gap junction protein Connexin 43 (Cx43) is essential for the formation of heart structures like the conotruncus. This role is attributed to the function of Cx43 in cardiac neural crest cells, which migrate to the target tissue and contribute to heart development 9, 10 . In many systems, embryonic neural crest cells can undergo collective cell migration 7, 11 and require a tight regulation of the expression of the adherens junction protein N-cadherin 12, 13 . Both N-cadherin and Cx43 modulate cell migration 14, 15 and their interaction has been furthered explored in mesenchymal cells, where Cx43 was shown to modify the levels of N-cadherin at the cell membrane 16 . However, the mechanism driving this regulation remains unknown.
Here, we ask whether Cx43, one of the most widely studied gap junction proteins, regulates N-cadherin expression during collective cell migration and investigate the molecular nature of such regulation. We show that Cx43, a molecule primarily known for its membrane-linked activities, uses its tail isoform to control morphogenetic movements via transcriptional regulation of Ncadherin. This nuclear activity is independent of its function as channel in the cell membrane. Moreover, we identify its mechanism of action, showing that Cx43 regulation of Ncadherin is due to a direct interaction with the basic transcription factor 3 (BTF3). BTF3 is able to form a stable complex with polymerase II and is part of the transcription initiation complex 17, 18 . In more recent studies, BTF3 upregulation has been correlated with tumor prognosis 19, 20 and the transcriptional activity of BTF3 has been implicated in proliferation and cancer progression 20, 21 . Here, we demonstrate that Cx43-tail, BTF3 and Pol II altogether form a complex that directly binds to the n-cad promoter to modulate N-cadherin transcription. Furthermore, we show that this unexpected activity of Cx43 as a regulator of Ncadherin is conserved between amphibian and mammalian cells.
Results
Cx43 promotes neural crest migration via N-cadherin regulation. To examine the role of Cx43 in neural crest development, we used antisense morpholino knock-down (Cx43MO). Depletion of Cx43 impaired collective chemotaxis of Xenopus cephalic neural crest ( Fig. 1a, b ; Supplementary Movie 1), without affecting single cell motility ( Fig. 1c ; Supplementary Movie 2). On the cellular level, we found that Cx43 is essential for cell morphology and polarization ( Fig. 1d, e ). We next asked whether downregulation of Cx43 affects expression of N-cadherin, which induces cell polarity and is required for neural crest migration [11] [12] [13] . Cx43MO led to a reduction in N-cadherin protein ( Fig. 1f-i) , whereas the levels of other junctional proteins such as E-cadherin were unaltered ( Fig. 1j-l) . Analysis by QPCR and in situ hybridization showed that Cx43MO decreased ncadherin at the mRNA level ( Fig. 2a-c) , The effects of Cx43MO on neural crest migration ( Fig. 2d, e ), cell polarity ( Fig. 2f, g) , protrusions ( Fig. 2h, i) , and cell dispersion (Fig. 2j, k) were rescued by co-expression of n-cadherin mRNA, showing N-cadherin as the main Cx43 target in this process. Together these results show that Cx43 promotes neural crest migration by controlling N-cadherin levels.
Several experiments were performed to control for the specificity of our antisense morpholino treatments. First, 8-24 ng of two different morpholinos were used and because they generated identical efficiency and phenotypes ( Fig. 3c ), we show the results of only one of them, hereafter referred as Cx43MO. Second, efficiency of the morpholinos was determined by western blot against Cx43 (Fig. 3a, b) , whereas specificity was demonstrated by rescue with Cx43 mRNA that does not bind the morpholinos (Fig. 3c-e ). In addition, we showed by grafting experiments that Cx43 MO works in a cell autonomous manner ( Fig. 3f ) and that specifically affect neural crest migration without interfering with neural crest induction, as none of the early neural crest markers are affected by Cx43MO (Fig. 3g) . These experiments show that Cx43MO is a specific inhibitor of Cx43 during neural crest migration.
Cx43 20k isoform controls cell migration via N-cadherin. It has been shown in mammalian cells that Cx43 exists in two forms: the full-length molecule (Cx43FL), which is a component of gap junctions, and smaller carboxy-terminal fragments, being the most abundant the isoform of 20 kDa (Cx43-20k) 22, 23 . These isoforms are present in many cell systems and their function remains unclear. We determined the presence of Cx43 isoforms in Xenopus neural crest and examined their temporal expression during development. Cx43FL was expressed at similar levels throughout the developmental stages analyzed, whereas expression of shorter Cx43 isoforms, in particular Cx43-20k, increased just before the onset of neural crest migration ( Fig. 4a , b, stage 18 onwards), and we confirmed that these Cx43 isoforms are present in neural crest cells ( Fig. 4c) .
To test the effects of the Cx43-20k on N-cadherin regulation we selectively over-expressed constructs containing or lacking the 20k fragment (Cx43-20k or Cx43Trun, respectively, Fig. 4d ). Expression of Cx43-20k led to upregulation of N-cadherin mRNA in Xenopus cells ( Fig. 4e-g ). Reduction of n-cadherin expression and neural crest migration by Cx43MO can be rescued by Cx43FL or Cx43-20k, but not by Cx43Trun ( Fig. 4h-l ). In addition, Cx43 was coexpressed with N-cadherin in migrating neural crest ( Fig. 5a ) and the increase in Cx43-20 levels matched those in n-cadherin expression ( Fig. 5b) . These results indicate that the Cx43-20k contains the activity that controls N-cadherin expression and neural crest migration.
Next, we asked how this isoform is generated. Consistently with findings in mammalian cells [22] [23] [24] , analysis of the Xenopus Cx43 sequence show several putative internal ribosome entry site (IRES) (Fig. 5c ); however, the major Cx43 isoform observed correspond to the 20 kDa peptide (red arrow in Fig. 5d ). The Cx43-20k fragment contains two putative IRES (M213 and M279) with predicted sizes for the respective polypeptides of 20 and 11 kDa ( Fig. 5c ). However, expression of the Cx43-20k fragment in Xenopus embryos only generates a peptide of 20 kDa ( Fig. 5e ). Furthermore, expression of the Cx43-20k, but not the Cx43-11k, leads to N-cadherin upregulation ( Fig. 5f ). To further demonstrate that the Cx43-20k isoform is generated by internal translation we showed that mutation of the M213 blocks the production of Cx43-20k ( Fig. 5g, h) . Consistently with observations performed in mammalian cells 24 , we observed that the production of Cx43-20k in neural crest cells depends on hypoxia, since the levels of Cx43-20k are reduced or increased during inhibition or activation of the hypoxic factor Hif1α ( Fig. 5i, j) . Importantly, Hif pathway has been previously shown to be required for neural crest migration 25 . Together, these data show that like in mammalian cell [22] [23] [24] , Cx43-20k is produced by the internal translation site M213 generating a 20 kDa peptide that is able to control N-cadherin expression.
We show that the presence of Cx43-20k is conserved across species as it is present in mammalian HeLa cells ( Supplementary  Fig. 1a ) and is able to upregulate N-cadherin levels in HeLa cells ( Supplementary Fig. 1b-d ) and in amphibian XTC cells (Supplementary Fig. 1e ). In addition, inhibition of Cx43 channel activity by two gap junction blockers (F.F.A. and M.F.A.) did not affect Ncadherin expression ( Supplementary Fig. 1f -k). Together, these results suggest a role for Cx43-20k in controlling N-cadherin expression and cell migration independent of Cx43 channel activity.
Cx43-20K isoform is a transcriptional regulator of N-cadherin. To understand the underlying cellular mechanism of this N-cad transcriptional regulation, we investigated the subcellular localization of Cx43 and Cx43-20k. We observed that Cx43-20k, but not Cx43Trun, localizes in the nucleus of HeLa ( Fig. 6a ) and neural crest cells ( Supplementary Fig. 2a ). Furthermore, an antibody that recognizes the carboxy terminal of Cx43 revealed nuclear localization in neural crest ( Supplementary Fig. 2b ), HeLa cells ( Supplementary Fig. 2c ) and XTC cells ( Supplementary  Fig. 2d ). This result was confirmed by subcellular fractionation of Xenopus embryos, where Cx43-20k was detected in the nuclear fraction ( Supplementary Fig. 2e ). To investigate if the nuclear localization of Cx43 is required for N-cadherin expression and cell migration, we fused the binding domain of the human glucocorticoid receptor (GR) with GFP-tagged Cx43-20k (Cx43-20kGR-GFP; Fig. 6b ). This construct entered the nucleus of neural crest and HeLa cells only in the presence of dexamethasone (dxm) 26 (Fig. 6c , i). Inhibition of n-cadherin expression ( Fig. 6d -f) and cell migration ( Fig. 6g , h) induced by Cx43MO was rescued in embryos injected with Cx43-20kGR-GFP after dxm treatment ( Fig. 6d-h) . These results suggest that the nuclear localization of Cx43-20k is required for N-cadherin regulation and that this regulation is conserved across different cell types.
We next explored the role of Cx43-20k on N-cadherin regulation. It is possible that Cx43-20k controls n-cadherin mRNA levels by regulating transcription or mRNA degradation. We found no difference in the rate of n-cadherin mRNA degradation between CTLMO and Cx43MO embryos ( Fig. 7a -c), indicating that Cx43 does not regulate mRNA stability. To test whether Cx43-20k controls N-cadherin without the need of translation of other genes, we blocked protein synthesis using the translation inhibitor cycloheximide (CHX). Cx43-20kGR-injected embryos treated with CHX, followed by dxm addition, showed an upregulation of N-cadherin expression, similar to non-CHX treated embryos ( Fig. 7d, e ), suggesting a direct effect of Cx43-20k on n-cadherin transcriptional regulation.
Cx43-20k isoform interacts with the transcription factor BTF3. To further explore the mechanisms underlying N-cadherin regulation and translocation of Cx43-20k isoform to the nucleus, we performed mass spectrometry analysis of Hela cells transfected with Cx43-20k construct. Using 1.3-fold change as a minimal cutoff for consideration between immunoprecipitated (IP) and control samples 27 , we found 30 candidates that are nuclear proteins and interact with Cx43-20k ( Fig. 7f ), reflecting potential binding partners that may be involved in N-cadherin regulation. Examination of the Xenopus database (Xenbase) revealed that these 30 candidates are expressed in Xenopus laevis but only one is specifically expressed in migrating neural crest cells ( Fig. 7f, g) : the BTF3 18,28,29 . To test its possible function, we designed a BTF3MO and found that it inhibited neural crest migration and n-cadherin expression, similar to Cx43MO, and both phenotypes are rescued by full length BTF3 mRNA ( Fig. 8a-d ). BTF3MO decreased endogenous BTF3 levels ( Supplementary Fig. 3a ), and did not affect neural crest induction ( Supplementary Fig. 3b ). Coinjection of BTF3MO with Cx43-20k blocked the effects of Cx43-20k alone on n-cadherin expression ( Fig. 8e , f) and nuclear localization of Cx43-20k ( Fig. 8g ), indicating that BTF3 is required for Cx43-20k activity. On the other hand, inhibition of Cx43 by Cx43MO did not affect the nuclear localization of BTF3 ( Supplementary Fig. 3c ), suggesting that BTF3 localizes to the nucleus even in absence of Cx43, whereas Cx43 requires BTF3 to mediate its subcellular localization. These observations are consistent with the presence of a nuclear localization signal (NLS) in BTF3 30 and its absence in Cx43-20k. Indeed, expression of an NLS-depleted BTF3 construct failed to rescue Cx43-20k nuclear localization ( Fig. 8h ). Knock-down of BTF3 in mammalian cells ( Fig. 9a, b ) also impaired Cx43-20k nuclear localization ( Fig. 9c , d) and blocked N-cadherin expression induced by Cx43-20k ( Fig. 9e , f), arguing for a conserved role of BTF3 and Cx43-20k. Altogether these data show that Cx43-20k is translocated to the nucleus via the NLS domain of BTF3 to control N-cadherin expression in amphibian and mammalian cells.
As both BTF3 and Cx43 are localized in the nucleus ( Fig. 10a ) and BTF3 NLS is required for Cx43-20k nuclear translocation, we hypothesized a direct interaction between these proteins. To test for physical interaction between Cx43-20k and BTF3 in the nucleus, we used bimolecular fluorescence complementation system (BiFC), in which two VENUS components (VC and VN9m) form a fluorescent protein when brought into close apposition 31 . To build the BiFC system we fused the VENUS component (VC) to either Cx43-20k or Cx43Trunc, while the other VENUS component (VN9m) was fused to BTF3. Empty VC was used as a control. Cx43-20kVC co-injected with BTf3VN9m gave a positive signal not observed with other combinations (Fig. 10b ). Moreover, this signal was higher in the nucleus (Fig. 10c ). These data support a direct interaction between Cx43 and BTF3 in the nucleus.
Cx43-20k isoform and BTF3 binds to n-cadherin promoter. To verify the biochemical interaction of Cx43-20k and BTF3, we performed co-immunoprecipitation (IP). We found that endogenous Cx43-20k and BTF3 co-precipitate in Hela cells ( Fig. 10d ). Our experiments also confirmed that BFT3 interacts with polymerase II (Pol II; Fig. 10e ), as previously shown 17 . These results support the notion that three proteins, Cx43Tail, BTF3 and Pol II, interact and may function as a transcriptional complex in the promoter of n-cadherin. To test this possibility, we performed chromatin immunoprecipitation (ChIP). We examined whether endogenous Pol II binds to the promoter of n-cadherin in the presence or absence of Cx43, by performing PCR against the . a Western blot for Cx43 and α-tubulin, from st23 embryo lysates. b Cx43 levels were normalized to α-tubulin and plotted (N = 3). c Analysis of neural crest migration by ISH for twist in st24 embryos, arrows show normal and brackets impaired migration. Co-injection of either of the MOs with human Cx43FL mRNA, which does not bind the MOs, but is highly conserved with Xenopus Cx43, showed a rescue in neural crest migration confirming the specificity of these treatments. d Neural crest migration index for each treatment. The length of each cephalic neural crest stream was measured in the injected (experimental) and uninjected (control) of the same embryo, and the migration index was defined as the ratio between experimental and control stream length. e % of embryos with normal neural crest migration in each treatment (n CMO : 89, n CxMO1 : 78, n CxMO1+FL: 85, n CxMO2 : 74, n CxMO2+FL : 95, N = 4). Note that there is no significant difference between the phenotypes produced by the two morpholinos (n.s. in d and e). f CMO-or CxMO-NC transplanted into uninjected host embryos showing tissue-autonomous function. Migration index of st24 transplanted neural crest (n CMO = 35, n CxMO = 37, N = 3). g St 16 embryos were analyzed by ISH for the early expression of neural crest markers sox9, sox10, snail2, foxD3, twist or C3, asterisk indicates the injected side (n CMO = 50; n CxMO = 50, N = 3). Scale bar in c, f, and g = 50 μm. Histograms in b and e represent mean ± SE (one-way ANOVA p < 0.001, two-tailed t test p * < 0.05, p ** < 0.01, p *** < 0.001). In d and f box plots show the median, box edges represent the 25th and 75th percentiles, and whiskers show spread of data including outliers (Mann Whitney test p *** < 0.001). N number of independent experiments; n sample size. Spread of data in bar charts is shown as overlying dots. n.s. nonsignificant n-cadherin promoter region of CTLMO and Cx43MO ChIP samples ( Supplementary Fig. 4 ). We detected Pol II enriched at the ncadherin promoter in CTLMO ChIP samples, whereas this enrichment was four times lower in ChIP samples collected from Cx43MO-injected embryos (Fig. 10f ). These results show that Cx43 is required for Pol II to bind at the n-cadherin promoter region. To test whether Cx43-20k is recruited to the n-cadherin promoter, we performed ChIP using Cx43-20kGFP or GFP (as a negative control) on embryonic lysates. ChIP-PCR analysis showed that Cx43-20k was enriched by three folds at the n-cadherin promoter region ( Fig. 10g ). Therefore, we propose that Cx43-20k together with BTF3 and Pol II form a complex that controls the transcriptional activity of n-cadherin at its proximal promoter.
Discussion
Although it was formerly speculated that connexin proteins may control gene transcription [2] [3] [4] , there was no direct evidence that this occurred and any underlying molecular mechanism remained unknown. Our results are consistent with previous studies showing that connexin fragments are found within the nucleus 4 , and that inhibition of connexins have significant effects on cell differentiation [2] [3] [4] . In previous studies, it has been proposed that the generation of these connexin fragments is controlled by the PI3K/AKT/mTOR pathway in mammalian cells 22 , the Mnk1/2 pathway in various cancer cell lines 23 and hypoxic conditions 24 . It is plausible that similar mechanisms are at play in our system. Indeed, in neural crest, the PI3K/AKT/mTOR pathway is 32, 33 and could, therefore, be implicated for the generation of connexin fragments. In our study, we show that Cx43 fragments appear at the onset of neural crest migration which coincide in time and space with the activity of Hif-1α (hypoxiainducible transcription factor-1), which is known to regulate neural crest migration 25 . Indeed, our data show that the generation of Cx43 isoforms is regulated by Hif-1α in embryonic Xenopus neural crest, similar to mammalian 24 .
Here, we show that these connexin fragments directly regulate n-cadherin expression. In mesenchymal cells it has been shown that Cx43 and N-cadherin regulate reciprocally each other's levels on the cell surfaces and it has been postulated that N-cadherin and Cx43 share similarities in their regulatory pathways 16 . Such regulation was mainly attributed to their functions at the cell membranes 16, 34 . Our results show that Cx43 controls the transcription of N-cadherin, which in turn is required for directional cell migration and cell polarization, a finding that is consistent with known activities of Cx43 in cardiac neural crest in mice 14, 15 .
Here, we show that Cx43, independent of its regulation on the cell membrane, via its small isoform that localizes at the nucleus directly affects n-cadherin transcription. It is tempting to speculate that Cx43 may control expression of other genes, in other cell types. Former in vitro studies have proposed an indirect role for Cx43 in gene regulation, such as with members of the CCN family or Smads 31, [35] [36] [37] . Our data demonstrate that the carboxyterminal fragment of Cx43 plays a direct role as a transcriptional regulator of gene expression in vivo. Several transcription factors have been shown to regulate n-cadherin gene expression such as FoxD3 38 or factors from Sox family, which bind to the enhancer regions of n-cadherin gene 39 . Gene regulatory networks for the neural crest place N-cadherin downstream of these transcription factors 40 , and our results place Cx43 as an additional regulator of n-cadherin in the neural crest gene regulatory network.
Here, we show that the transcription factor BTF3 binds to the promoter region of n-cadherin 41 with the help of Cx43 and together positively regulate n-cadherin expression. Thus, BTF3, a transcription factor previously associated with gene expression in cancer systems 20, 21 , regulates embryonic gene expression in neural crest, a cell population that has been likened to cancer cells 42 . Cx43 has been postulated to be upregulated in later stages of neural crest development 40 as in several cancer systems 43, 44 , in order to modulate cell migration. Here, we provide evidence that three components associated with embryonic and cancer cell biology are part of a common pathway, an adhesion molecule (Ncadherin), fragments of another adhesion molecule (Cx43) and a transcription factor (BTF3).
In summary, we have identified an original pathway by which an adherens junction component, n-cadherin, is regulated by a protein normally associated with a gap junctional communication. This opens the possibility of cross-talk between processes mediating intercellular communication and cell-cell interaction, unveiling a mechanism of cross-regulation between gap and adherens junctions at the transcriptional level. The high conservation of Cx43 across different taxa and the presence of Cx43Tail in various vertebrate systems may reflect an evolutionary conserved mechanism of gene regulation by a protein previously well-known by its gap junction activity.
Methods
Embryo manipulation. Adult X. laevis were maintained at 17°C and used according to the regulations of the Biological Service Unit at University College London, complying with the UK Home Office guidelines established in the Animals Act 1986 as described 45 . X. laevis embryos were obtained and staged as previously described 46, 47 . To specifically target the neural crest, embryos were injected into the animal ventral blastomeres at the eight-cell stage on one side for all experiments, except when embryonic lysates were used. In this case embryos were injected in both animal sides of two-cell stage embryos. Embryo microinjections were performed according to 48 . If required, fluorescein-dextran (FDx; Invitrogen, D1821, 20 ng) or rhodamine-dextran (RDx; Invitrogen, D1824, 20 ng) were used as tracers. Oligomorpholinos against X. laevis Cx43 (Cx43MO1; 8-24 ng, 5′-TTCCTAAGGCACTCCAGTCACCCAT-3′, Cx43MO2; 8-24 ng, 5′-AAAAATGGTTTTCTTGTGGGTCGA-3′) and BTF3 (BTF3MO, 40 ng, 5′-AACGGACCGGGTTTAAAGGCTTCCT-3′) were synthesized and provided by Gene Tools LLC. Equimolar concentrations of standard control morpholino (CTLMO: 3′-ATATTTAACATTGACTCCATTCTCC-5′) were used. The amounts of morpholinos correspond to the amounts injected in one side of eight-cell stage embryos, while the other side was used as an internal control. When embryos were used for collection of embryonic lysates, they were injected at two-cell stage in both animal blastomeres and double of the mentioned dosages were used. To test the efficiency of Cx43MOs on the endogenous cx43 mRNA, we performed western blot analysis. Both Cx43MOs efficiently lowered the protein levels of the endogenous Cx43FL and Cx43iso (Fig. 3a, b) . In order to validate BTF3MO efficiency, we tested by immunostaining of neural crest cells the BTF3 protein expression, which showed decreased levels of BTF3 in BTF3MO cells compared to CTLMO (Supplementary Fig. 3a ).
In situ hybridization was performed as previously described 49, 50 . Briefly, embryos were fixed in MEMPFA, followed by overnight hybridization with digoxigenin-labeled probes, incubated with an AP antibody and AP activity was developed using NBT/BCP substrates. Digoxigenin-labeled RNA probes were prepared for foxD3 48 snail2 51 , twist 52 , n-cadherin 53 , C3 53 , btf3 (Xenbase: XL075i22), and sox10 54 , sox9 54 . C3 (1 μg/ml), snail2 (0.8 μg/ml), foxD3 (2 μg/ml), sox10 (1 μg/ml), sox9 (1 μg/ml), and twist (0.7 μg/ml) were used to assess neural crest induction, twist (0.7 μg/ml) for neural crest migration, n-cadherin (1 μg/mL) to assess expression levels and btf3 (0.7 μg/mL) expression pattern. Whole-mount immunostaining was carried out as previously described 55 using Cx43 antibody (1:1000, Sigma, C6219). Briefly, embryos were fixed in MEPMFA and incubated overnight with the antibody at the described dilution.
Animal cap explants were dissected from Xenopus blastulas (stage 8) using a standard technique 48, 56 and prepared for in situ-hybridization as described above. For animal cap assays, 500 pg mRNA was injected into the animal side of the two blastomeres of two-cell stage embryos. Analysis of ISH was performed on 20-25 embryos per condition for each independent experiment.
Neural crest manipulation and imaging. Neural crest transplants were carried out as previously reported 57 . Briefly, neural crest taken from stage 18 fluorescently labeled embryos were dissected with eyebrow knives and grafted into unlabeled host embryos. For in vitro experiments, cranial neural crest explants were dissected at stage 18 using a standard technique 58, 59 and plated on fibronectin (Sigma, F1141) coated dishes as previously described 53 . For single cell assays, neural crest cells were briefly dissociated in Ca2+/Mg2+-free Danilchick medium 53 . For each condition, ten embryos transplanted with fluorescent labeled NC were analyzed per experiment.
Immunostaining was performed on neural crest explants as previously described 54 using anti-N-cadherin (1:50, rat IgG, clone MNCD2, DSHB), anti-Ecadherin (1:250, mouse IgG, clone 5D3, DSHB), anti-BTF3 (1:100, Abcam, ab107213), anti-rabbit IgG Alexa488 (1:500, Invitrogen, A11034) and anti-rat IgG Alexa488 (1:500, LifeTechnologies). When required, 4′,6-diamidino-2phenylindole (DAPI; 1 μg/mL, Sigma, D9542) and/or phalloidin tetramethylrhodamin-b-isothiocyanate (PhR; 1 μg/mL, Sigma, P1951) were used.
Imaging of fixed embryos was performed using a MZFLIII Leica fluorescence stereomicroscope equipped with a DFC420 Leica camera controlled by Leica IM50 software. Imaging of in vitro neural crest migration was performed using time-lapse cinematography as described previously 53, 60 . Briefly, neural crest cells were cultured in plastic or glass petri dishes coated with fibronectin, and time-lapse microcopy was started after one hour of in vitro culture. For cell motility and migration, compound microscopes (either an Eclipse 80i Nikon microscope with a Hamamatsu Digital camera or a DMRXA2 Leica microscope with a Hamamatsu Digital camera controlled by Simple PCI program) equipped with motorized stages and a 10×/0.30NA dry lens were used. NC cultures were prepared as described above. Images were acquired every 5 min for a period of 12 h. For cell morphology imaging, a TCS SP8 microscope with a 63 × /0.90NA water immersion objective lenses and controlled by LAS-AF software was used. Fixed cells were imaged using a 63 × /1.4NA oil immersion objective and a Leica TCS SPE confocal microscope controlled by LAS-AF software. Cx43-20 kDa isoform is generated from Internal Ribosome Entry Site (IRES). a twist ISH lcompared with Cx43 immunostaining in stage 24 embryos; IgG control antibody; arrow: neural crest; asterisk: eye. Drawing: Cx43 and twist expression summary. Scale bar = 80 μm. b Cx43-20k protein levels (analyzed by WB) and N-cadherin mRNA (analyzed by qPCR) in st23 NC cells (n = 61 embryos, N = 3). c-h Cx43 putative IRES and activity of Cx43 isoforms. c Predicted methionine-initiated polypeptide. Green: constructs used in e. Red arrows: abundant peptides found in Xenopus; gray arrows: less abundant or absent peptides in Xenopus. d WB of embryos at NC migratory stages with antibody against the Cx43 C-terminus. Major bands correspond to Cx43FL and Cx43-20k (arrows). e WB of neural crest expressing the Cx43-20k-HA with an antibody against HA. The only band generated corresponds to the M276-initiated peptide (Cx43-20k). f Injection of Cx43-20k, but not Cx43-11k, leads to induction of N-cadherin expression in blastula embryos; percentage of embryos displaying N-cadherin expression, (n Cx43-11k = 20 embryos n Cx43-20k = 20 embryos, N = 3). Scale bar = 70 μm. g WB against Cx43 from embryos at st21 injected with Cx43-HA (lane 1) and with Cx43 mutated in methionine 213 (M213L Cx43, lane 2). h WB's quantification (n lane1 = 20 embryos n lane2 = 20 embryos, N = 4). i WB of st22 neural crest cells with antibody against the Cx43 C terminus. Lane1: control neural crest; lane 2: neural crest injected with Hif-1α morpholinos; lane 3: neural crest expressing a dominant active form of Hif-1α. j Quantification of Cx43 isoforms (n control = 50; n Hif-1αMO = 50; n Hif-1αΔ = 50 neural crests, N = 6 independent experiments). Hif-1αMO and Hif-1αΔ were previously validated 25 Cell migration and cell morphology analysis. Chemotaxis assay was performed following a standard procedure 61 using heparin acrylic beads (Sigma, H5263) coated with 1 μg/mL purified human stromal cell-derived factor-1 (Sigma, SRP3276). Cell motility and chemotaxis were analyzed using ImageJ (https://imagej.nih.gov) analysis tools, as described previously 53, 60 . Briefly, each individual cell was manually tracked using the Manual Tracking plugin of ImageJ, the data were collected and analyzed using the Chemotaxis plugin of ImageJ. Cell morphology was assessed by deploying the circularity index (complete circle = 1) and estimated by ImageJ analysis tools. Cell dispersion was analyzed using Delaunay triangulation algorithm (ImageJ Plugins) and was plotted as average explant triangle area, as described before 54 . Cell protrusive area was analyzed in neural crest cells at the edge of an explant measuring the outgrowing area that derives from two consecutive timeframes with 4 min time interval; these two consecutive frames were subtracted to generate the new area 12 Molecular biology, plasmids, and reagents. For cDNA synthesis, total RNA was isolated from 10-15 embryos stages 23-24 or 10-15 animal caps stage 8 from X. laevis per condition for each independent experiment and three technical replicas were used within each experiment 25 . Quantitative PCR (qPCR) was performed on an Applied Biosystems ABI 7900HT machine using the Fast SYBR Green Master Mix (Applied Biosystems, 4385612) and the following primers: ef-1 forward 5′-ACCCTCCTCTTGGTCGTTT-3′, ef-1 reverse 5′-TTTGGTTTTCGCTGCTTTC T-3′ 15 , ncad forward 5′-CAGGGACCAGTTGAAGCACT-3′, ncad reverse 5′-TGCCGTGGCCTTAAAGTTAT-3′ 62 . n-cad mRNA expression was plotted as relative expression normalized against the housekeeping gene ef-1.
Plasmids: Cx43 constructs were synthesized using the X. laevis Cx43 sequence from cDNA clone (UniGene ID XL.1109) as template. Full length Cx43 (Cx43FL, aa 1-379), Cx43 carboxy terminally truncated construct (Cx43Trunc, aa 1-212) and Cx43-20k construct (Cx43Tail, aa 213-379) were cloned into 5′BamHI/3′XhoI of pCS2+ or pCS2-EGFP vectors. The pCS2-EGFP vector was kindly provided by Dr. Masa Tada. Inducible construct of Cx43Tail was prepared by fusing the Cx43-20kTail (aa 219-379) to the ligand-binding domain of the human GR (aa 512-777). Cx43-20k was cloned into 5′EcoRI/3′SacI and GR into 5′SacI/3′XhoI of pCS2+ and pCS2-EGFP. BTF3 constructs were synthesized using the X. laevis sequence from cDNA clone (UniGene ID XL.3536). BTF3FL (aa 1-162) was cloned into 5′ EcoRI/3′XhoI of pCS2+ or pCS2-EGFP. BTF3 deletion construct lacking the NLS region RRKKK (BTF3-dNLS, aa 1-158) was cloned into 5′BamHI/3′ClaI of pCS2+. For the BiFC experiments (Fig. 4b, c ), Cx43Tail and Cx43Trunc were cloned into 5′BamHI/3′BamHI of pCS2-VC155. BTF3FL was cloned into 5′ BamHI/3′BamHI of pCS2-VN9m. BiFC vectors were kindly provided by Prof James C. Smith. All construct sequences are verified by automated DNA sequencing (Source Biosciences, UK). When required, plasmids were linearized and mRNA transcribed as described before 25 , using sp6MessageMachine (Ambion). The mRNA constructs injected were: membrane GFP (mGFP, 300 pg), membraneRFP (mRFP, 300 pg) nuclearRFP (nRFP, 300 pg), lifeactin-GFP (400 pg), N-cadherin-GFP (500 pg), Cx43FL (500 pg), Cx43Trunc (500 pg), Cx43-20k (500 pg), BTF3FL (500 pg), BTF3-dNLS (500 pg), Cx43-20k-VC (500 pg), Cx43Trunc-VC (500 pg), and BTF3-VN9m (500 pg). The following plasmids were ; ΔΜ213 Cx43 (800 pg/embryo, 63 ). All analysis on fluorescent constructs was assessed by normalizing to the background fluorescence and when required, to total cell area fluorescence.
The following reagents were used: flufenamic acid (50 μM for NC explant incubation −100μM for embryo treatment, Sigma, F9005), meclofenamic acid (50 μM for NC explant incubation −100μM for embryo treatment, Sigma, M4531), actinomycin D (20 μM, Sigma, A1410), CHX (10 μM, Sigma, C7698) and ethanoldissolved dexamethasone (10 μM) was added to the culture medium at stages 14-15 and maintained until neural crest migratory embryonic stages (stage 23). To control the possible leakage of inducible chimeras, a sibling batch of embryos were cultured without dexamethasone and processed for in situ hybridization. For coupling test (testing gap junction channel activity), 10-15 NCCs were analyzed per condition per experiment.
Immunoprecipitation, fractionation, and western blotting. For each condition 10-15 embryos were used for preparation of embryo lysates per experiment. Whole embryos were prepared for western blot after homogenization in lysis buffer (20 mM Tris, 100 mM NaCl, 0.01% Triton-X, pH 8.0) with added protease inhibitors (Roche, 11836153001) and phosphatase inhibitors (Roche, 04906837001) 54, 64 . For western blots, the following antibodies were used: Connexin 43 (Sigma, C6219, 1:1000), N-cadherin (DSHB, clone MNCD2, 1:800), Ecadherin (DSHB, clone 5D3, 1:1000), p42/44 MAPK (Cell Signaling, 9102S, 1:2000), α-tubulin (DSHB, clone 12G10, 1:1000), phospho-histone H3 (Millipore, 06579, 1:2000), GFP (Invitrogen, A11122, 1: 2000), HA-tag (Sigma H6908, 1:2000), rabbit IgG HRP-linked (Amersham ECL, NA934, 1:3000), mouse IgG HRP-linked (Amersham ECL, NA931, 1:3000) and rat IgG HRP-linked (Sigma, A9037, 1:2000). Immunoprecipitation was performed using GFP-Trap ® kit (Chromotek); briefly, cells were suspended in lysis buffer and centrifugated at 20,000×g for 5 min at 4°C, the supernatant was recovered and the volume adjusted with dilution buffer. Beads were equilibrated in dilution buffer and mixed with the resuspended cell lysate. The mix was magnetically purified and prepared for western blot. Nuclear fraction isolation of X. laevis embryos was performed using differential centrifugation protocols with modifications 64, 65 . Briefly, stage 18 X. laevis embryo lysates using a 22 G needle and 20 μL homogenization buffer (HB: 250 mM sucrose, 20 mM Hepes, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, phosphatase and protease inhibitors) per embryo. All samples were Cx43-20Kd isoform interacts with BTF3 to regulate N-cadherin transcription. a Summary of the actinomycin D treatment. CxMO injection in embryos at the two-cell stage, followed by incubation with 4 μg/ml of the transcriptional inhibitor actinomycin D and harvested for qPCR at the indicated times. b qPCR of st23 neural crest plotted as relative n-cad expression over time. The slope of these curves represents the N-cad mRNA degradation rate on time, which is shown in c (N = 5). d Blastula embryos analyzed by ISH for n-cad after the indicated treatments. Scale bar = 40 μm. e Quantification of data shown in e as % of embryos expressing n-cad analyzed by ISH at blastula stage embryos (n CTL = 35, n Cx43-20kGR = 46, n Cx43-20kGR+dxm = 55, n CTL+cyc = 65, n Cx43-20kGR+cyc = 57, n Cx43-20kGR+dxm+cyc = 64, N = 3). f Summary of mass spectrometry results to identify Cx43-20kD binding partners. Left: Pie chart of Cx43-20 kD interactants. Right: Venn diagram of interactants found in nucleus. The Cx43-20kD binding partner shown in green corresponds to BTF3. g In situ hybridization for btf3, twist, and n-cad in st24 embryos, arrows show neural crest and asterisk the eye. Scale bar = 50 μm. Note that btf3 and n-cad are coexpressed in the migrating neural crest (identified by twist expression), and in the eye and neural tube. Summary of btf3, twist and n-cad expression profiles. Histograms in c and e represent mean ± S.E. (in e one-way ANOVA p < 0.001, two-tailed ttest p ** < 0.01, p *** < 0.001). N number of independent experiments; n sample size. Spread of data in bar charts is shown as overlying dots. n.s. nonsignificant centrifuged at 250×g for 5 min to remove embryo debris. After collecting the supernatant, it was distributed to three different tubes and spun at three different speeds (400×g, 600×g) for 5 min to isolate the cell nuclei. The postnuclear supernatants were kept for further processing. The nuclear pellets were washed once more in buffer HG and centrifuged at the appropriate speed (400×g, 600×g). Nuclear pellets were then resuspended in 40 μL 10% glycerol/0.1% SDS/1% Triton-X in HB. Appropriate amount of sample buffer was added to each sample, and samples were processed for acrylamide gel electrophoresis and western blot analysis. In order to avoid loading errors, the same membrane was blotted against the loading control after stripping as described before 54, 64 .
Western blot data were analyzed using ImageJ analysis tools. Image intensities were normalized and the ratio of the protein of interest to loading control (i.e., Mapk or α-tubulin) was calculated, average ratios were plotted. Uncropped blots are included as supplementary figures (Supplementary Figs. 5-7) . Xenopus embryonic fibroblasts (XTC, a kind gift from Ana Losada) were cultured in 67% DMEM/H2O supplemented with 10% fetal calf serum at 25°C in a humidified atmosphere of 5% CO 2 and transfected as indicated using Viafect (Promega, USA). Plasmids for transfection were as indicated and 10-20 Hela or XTC cells were analyzed for each condition per experiment.
For siRNA experiments, a combination of three siRNA targeted against BTF3 were transfected as described above. A standard siRNA (scrambled siRNA from Sigma) was used as a control. Catalog number for these commercial siRNA against BTF3 are: SASI_Hs01_00124567; SASI_Hs02_00308337; SASI_Hs01_00124566. Cells were collected 48 h after transfection and processed for qPCR, western blot, or Immunohistochemestry experiments. As described in the respective sections.
All cell lines were tested for mycoplasma contamination.
Immunohistochemestry and phalloidin staining. For protein detection, mammalian cells or neural crest explants were fixed in 4% formaldehyde in 0.2% PBS-T (PBS + 0.2% Triton X-100) for 10-min and blocked with 10% NGS for 1 h. Primary antibodies were incubated ON at 4°C in 10% NGS. The following antibodies were used: 1/100 anti-BTF3 (Abcam, ab107213), 2.5 µg/ml of anti-N-cadherin (MNCD2 Developmental Studies Hybridoma Bank), and 1:100 anti-Cx43 (Sigma, C6219) in 10% NGS and incubated ON at 4°C. Explants were washed 3 times with PBS + 0.2% Tween-20 and incubated ON at 4°C with secondary antibody, diluted at 1:350 in 10% NGS. DAPI was diluted at 1:1000 and mixed with the secondary antibodies.
Mass spectrometry. For co-immunoprecipitation of the FLAG-tagged Cx43Tail for mass spectrometric analysis cells were lysed and lysates were incubated overnight with anti-HA and equilibrated high affinity beads at 4°C, the immunoprecipitates were then washed and eluted 27 . Subsequently of acid elution with 0.1 M glycine pH 2.5, the pH of the eluates was adjusted to pH 8.0 with 0.5 M Tris. For protein digestion samples were incubated overnight with 2 µg trypsin (Trypsin Gold, Promega, USA) followed by addition of 0.1 µg Lys-C (Roche, Germany) and incubation for additional 6 h. The peptides were desalted on C-18 reversed phase stage tips (Nest Group, USA), dried in vacuum and stored at −20°C until analysis. Dried peptides mixtures were recovered in 3 µl 30% formic acid and diluted with water to 23 µl. Five µl of the digest were injected on a Nano-LC system (Eksi-gent425 2D Nano-LC; Sciex, USA) and peptides were separated by reversed phase chromatography on C-18 columns prepared in-house (Reprosil-Pur C18-AQ, Coupling assay. Gap junction intracellular communication was tested using a dye coupling assay. Here, the fluorescent dye Calcein-AM (Sigma, 17783) was used. A neural crest population dissected from uninjected embryos was incubated with the dye Calcein-AM for approximately 10 min or until the dye was loaded into all the cells. Another neural crest population from embryos injected with a nuclear marker (nRFP mRNA injections, see above) was dissected separately. After the two populations were dissociated in absence of calcium and magnesium, they were mixed and incubated for 1 h at 14°C in a test tube. Following mild centrifuge, the neural crest explants were cut in similar size pieces and cultured as described above and then filmed. To test the channel activity of gap junctions, gap junction blockers; meclofenamic acid (Sigma, M4531) and flufenamic acid (Sigma, F9005) were used. Cell communication was assessed by estimating the ratio of number of cells that display both tracers, the nuclear marker and the Calcein to the total number of cells that have the nuclear marker.
Statistical analysis. The estimation of the sample size was done by following previously published work and no specific statistical method was used. Experiments were not randomized and due to the nature of the experiments, the authors were not blinded to allocation during both, experiments and results analysis. Only viable embryos and explants were analyzed. Mis-injected embryos were not included for in situ hybridization experiments. Correct injection was determined by injection of linear tracers. Our experimental parameters were measured at random once viable and properly injected embryos were selected. Comparison of percentages was performed using contingency tables 66 . Normality of data sets was tested using Kolmogorov-Smirnov's test, d'Agostino and Pearson's test and Shapiro-Wilk's test using Prism6 (GraphPad). Datasets following normal distribution were compared with Student's t-test (two-tailed, unequal variances) or ANOVA with a Dunnett's multiple comparisons post-test using Excel or Prism6 (GraphPad). Datasets that did not follow a normal distribution were compared using Mann Whitney's test or a nonparametric ANOVA (Kruskal Wallis with Dunn's multiple comparisons post-test) using Excel or Prism6. Cross-comparisons were performed only if the overall p value of the ANOVA was less than 0.05. In all figure legends N = number of independent experiments; n = total sample size.
X. laevis n-cadherin partial promoter identification. To identify the basic promoter of Xenopus n-cad we used the following strategy. The basic promoter region from chick and mammalian n-cadherin genes have been described at the 5′-UTR regions, within the position −3000 to −1 bp respect the translation initiation site 41, 67 . By using the X. laevis Genome Project resource (https:// xenopus.lab.nig.ac.jp/) we identified a region of 2800 bp in the 5′-UTR of the X. laevis n-cadherin gene ( Supplementary Fig. 4 ). Since our data indicate that Cx43Tail, BTF-3, and Pol II form a complex, we use ElemeNT tool 68 to search for potentially active TATA boxes in the region that we isolated. Our in silico analysis reveal a TATA box rich region between the positions −166 to −618 bp, relative to the translation start site ( Supplementary Fig. 4 ). Finally, we design overlapping primers to amplify fragments of 200 bp across this region. Primers sequences are listed in the ChIP section and their binding regions are highlighted in Supplementary Fig. 4 .
Chromatin immunoprecipitation (ChIP). For chromatin immunoprecipitation (ChiP), we followed a standard procedure for X. laevis embryos 69, 70 . For each independent experiment we used two technical replicas and 250-300 Xenopus embryos per condition. Briefly, neurula stages X. laevis embryos were fixed for 15 min and 3 μg of Pol II antibody (Diagenode, C15100055) or GFP ChIP grade antibody (Abcam, ab290) were used. For DNA extraction we followed a standard protocol 69, 70 . Using the ElemeNT analysis resource, we searched for putative TATA boxes in the X. laevis n-cad promoter region ( Supplementary Fig. 4 ). Primers flanking these TATA boxes were designed to analyze ChiP samples by PCR. PCR was performed using the following protocol 95°C for 30 s, 56°C for 40 s, and 72°C for 30 s for 32 cycles. Primers used for ChiP-PCR were:
P5F: 5′-CTTCCAAGAGATGAAGCTCATAT-3′, P5R: 5′-AACACTCTATATGGCAGATAAC-3′, P6F: 5′-CCTTTAAATGCATACACTTACC-3′, Supplementary Fig. 4b . ChIP experiments were quantified as follow: normalized ratio of band intensity for each condition was averaged it and the fold increase respect the IgG control was calculated and plotted as fold enrichment. Band intensity was registered by using ImageJ Gels analysis plugin. Uncropped gels are shown in Supplementary  Fig. 7c, d .
Data availability
All data and custom codes are available upon reasonable request to the corresponding author. The mass spectrometry proteomics data have been deposited to the Proteo-meXchange Consortium via the PRIDE partner repository with the dataset identifier PXD010870 Received: 5 March 2018 Accepted: 29 August 2018 . Histograms in c, f, and g represent mean ± SE (one-way ANOVA p < 0. 001, two-tailed ttest p ** < 0.01, p *** < 0.001). N number of independent experiments; n sample size. Spread of data in bar charts is shown as overlying dots. n.s. nonsignificant
